Received Apr 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
joint pain; Lost my voice; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of joint pain in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced joint pain (Verbatim: joint pain) and loss of voice (Verbatim: Lost my voice). The outcome of the joint pain and loss of voice were not resolved. It was unknown if the reporter considered the joint pain and loss of voice to be related to RSV vaccine. It was unknown if the company considered the joint pain and loss of voice to be related to RSV vaccine. Additional Information: GSK Receipt Date: 21-APR-2025 The patient self reported this case for himself/herself. This case was reported by a patient via interactive digital media. Patient have never had bad reactions to vaccines, so he/she did not hesitate to get the RSV one. Patient still having joint pain a month and a half after receiving it. Lost his/her voice and it was still not back to normal. It turned out that vaccine effects could be unpredictable.